Imatinib Improves Hemodynamics And Quality Of Life In Pulmonary Arterial Hypertension

被引：0
|
作者：
Somaini, S. Ulrich
Vatandaslar, S.
Huber, L. C.
Treder, U.
Breitenstein, A.
Speich, R.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6442
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition?
    Vinke, Paulien
    Jansen, Suzanne M.
    Witkamp, Renger F.
    van Norren, Klaske
    HEART FAILURE REVIEWS, 2018, 23 (05) : 711 - 722
  • [32] Pulmonary arterial hypertension: the burden of disease and impact on quality of life
    Delcroix, Marion
    Howard, Luke
    EUROPEAN RESPIRATORY REVIEW, 2015, 24 (138): : 621 - 629
  • [33] Quality of life in pulmonary arterial hypertension: Improvement and maintenance with bosentan
    Keogh, Anne M.
    McNeil, Keith D.
    Wlodarczyk, John
    Gabbay, Eli
    Williams, Trevor J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : 181 - 187
  • [34] Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition?
    Paulien Vinke
    Suzanne M. Jansen
    Renger F. Witkamp
    Klaske van Norren
    Heart Failure Reviews, 2018, 23 : 711 - 722
  • [35] Combination Therapy with Rapamycin and Imatinib in Pulmonary Arterial Hypertension
    Shi, Y.
    Desai, A. A.
    Tang, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [36] Population pharmacokinetics of imatinib in patients with pulmonary arterial hypertension
    Bouillon, Thomas
    Renard, Didier
    Zhou, Ping
    Flesch, Gerard
    Quinn, Debbie
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [37] Role Of Kit Inhibition By Imatinib In Pulmonary Arterial Hypertension
    Farha, S.
    Dweik, R. A.
    Rahaghi, F. F.
    Benza, R. L.
    Hassoun, P. M.
    Frantz, R. P.
    Torres, F.
    Quinn, D.
    Comhair, S. A. A.
    Erzurum, S. C.
    Asosingh, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [38] Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension
    Chhina, Mantej K.
    Nargues, Weir
    Grant, Geraldine M.
    Nathan, Steven D.
    FUTURE CARDIOLOGY, 2010, 6 (01) : 19 - 35
  • [39] Positioning Imatinib for Pulmonary Arterial Hypertension (PIPAH) study
    Rothman, A.
    Villar, S.
    Middleton, J.
    Law, M.
    Varian, F.
    Zafar, H.
    Kiely, D. G.
    Roussakis, A.
    Howard, L.
    Toshner, M.
    Wort, J.
    Wilkins, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [40] Obesity and Quality of Life in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR)
    Min, J.
    Benza, R. L.
    Feldman, J. P.
    Rosenzweig, E. B.
    Horn, E.
    Sager, J. S.
    Presberg, K. W.
    Shlobin, O. A.
    Mathai, S. C.
    McConnell, J. W.
    Burger, C. D.
    Frantz, R. P.
    Klinger, J. R.
    Ventetuolo, C. E.
    Eggert, M.
    Zamanian, R. T.
    Robinson, J.
    Lammi, M. R.
    De Marco, T.
    Allen, R.
    Elwing, J. M.
    Bull, T. M.
    Badesch, D. B.
    Williamson, T. L.
    Ramani, G.
    Thenappan, T.
    Ford, H. J.
    White, R.
    Runo, J. R.
    Simon, M.
    Bartolome, S.
    Hemnes, A.
    Grinnan, D.
    Chakinala, M. M.
    Kawut, S. M.
    Al-Naamani, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345